Navigation Links
Fiberoptic Green System Blade Miller

ProductsFiberoptic Green System Blade Miller
Company Rusch, Inc.
Item Fiberoptic Green System Blade Miller
Features 
  • 5.0mm diameter fiberoptic light pipe
  • No crevices or hard to reach areas
  • Green system fitting to ISO 7376-3 specifications
  • Lifetime warranty; free from manufacturing defects
  • Matte finish
  • Bright, focused light
  • Easy to clean
  • Reduced glare from the blade
  • Interchangeable with other Green systems
    • Description Greenspec Laryngoscopes are a high quality fiberoptic system designed to meet the need of bringing greater standardization to fiberoptic laryngoscopes. The green color coding identifies it as fiberoptic and indicates it's ability to interconnect with other green coded systems. The Halogen Fiberoptic light offers a cool, bright and focused light. The Greenspec pivot designs will accept other green coded fiberoptic systems. The Greenspec is available in Miller and Miller 0 with Oxiport connectors. The green color coding allows for easy identificaiton of the fiberoptic system.
    Info Rusch, Inc.
    Customer Service: (800) 514-7234
    Web site: http://www.rusch.com/

    Related medicine products :

    1. Coaxial Fiberoptic Headlights
    2. Fiberoptic Lightweight Coaxial Rotary Headlight
    3. Neuroview Rigid Body Fiberoptic Neuroendoscopes
    4. Fiberoptic CIS Set
    5. Fiberoptic Light Guide, snap-on
    6. Fiberoptic Light Guide, clip-on
    7. High Transmission Autoclavable Fiberoptic Light Guide, snap-on
    8. High Transmission Autoclavable Fiberoptic Light Guide, with 45 angled instrument fitting, snap-on
    9. Fiberoptic Light Guide with Fixed ACMI™ Light Source End
    10. Universal Fiberoptic Light Guide (without adapters)
    11. Fiberoptic Green System Laryngoscope Handles
    ...ver the age of 3 can choose either the PARI LC PLU...iple applies to both:, ,Maximize aerosol output w...t when the patient exhales using two one-way valve...e the nebulizer. The result is a high percentage o...
    ...th metered dose inhalers., ,ACE ensures prompt, e...DI canisters. Its versatile design allows it to be... an endotracheal airway or resuscitation bag and f...in conjunction with an incentive spirometer to hel...
    ...zer Small Volume Medication W/Adult Mask PT WYE Mo...ced jet design for fast treatment times , ,Provid...er percentage of respirable particles) than conven...y Max 10™ disposable nebulizers deliver fast...
    ... in Anesthesia and Respiratory Products, ,Westmed...y medical devices for Anesthesia and Respiratory p...ture products that enhance the clinician's ability...e attention to the bottom line. , ,Our web site i...
    Medicine Products:
    (Date:1/8/2009)...LLAS, Jan. 8 A study released this...re suffering from multiple chronic diseases shines...U.S. health care system to one that focuses on pri...reventive Medicine, the leader in disease preventi...in/prnh/20080506/NETU129LOGO ) , , The study,...
    (Date:1/8/2009)...lifornia Assembly Member Tom Torlakson Introduces ...e-USNewswire/ -- Today, Lung Cancer Alliance-Cal...r Tom Torlakson (D-11th District) for his continue...funding for lung cancer research. For the third c...cancer research is being considered in the Califor...
    (Date:1/8/2009)...e not quick to condemn hurtful comments, study sug...ews) -- Many people overestimate how strongly they...says. , Sixty-three percent of study participa... partner for an experiment with a white person rat...made racist comments about the black person when h...
    (Date:1/8/2009)...THESDA, Md., Jan. 8 Han...ed to announce that throughout the fourth quarter ...hotics Center, Rocky Mountain Orthotic-Prosthetics...ces, Inc., First Coast Orthotics & Prosthetics...se acquisitions add patient care centers to existi...
    Breaking Medicine News(10 mins):Health News:U.S. Preventive Medicine: Chronic Disease Study Demonstrates Need for Focus on Primary and Secondary Prevention 2Health News:Lung Cancer Alliance Applauds New Legislation Funding Lung Cancer Research 2Health News:Many Turn Blind Eye to Racism 2Health News:Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue 2
    ...that share many characteristics with normal stem c...promoting tumor blood vessel// formation, and may ...esearch team reported in the August 15th issue of ...M.D., associate professor at the Preston Robert Ti...
    ...motherapy, ovarian cancer is still the most lethal... cause of cancer death among women// in the United...rates for ovarian cancer have remained stubbornly ...nd mimic other conditions, and the lack of a cost-...
    ...artment of Health to find the response time of amb...t six trusts// had failed to record correct detail...threatening emergency calls. The Government has ...h 'Category A' calls should be responded to within...
    ...versity of Michigan Depression Center, most of the...ting// any treatment nor are the ones with the ris...ion. In the latest issue of General Hospital Psyc...ven those who are getting some kind of treatment, ...
    Other Medicine News:Health News:Cancer Stem Cells Could Hold Key to Brain Tumor Therapy 2Health News:New Approach to Early Detection of Ovarian Cancer 2Health News:Incorrect Recording Of Response Time By Six Ambulance Trusts 2Health News:No therapy for most of the pregnant women with depression 2Health News:No therapy for most of the pregnant women with depression 3Health News:No therapy for most of the pregnant women with depression 4
    (Date:1/7/2009)...ire-FirstCall/ -- Eli Lilly and Company,(NYSE: ...response letter from,the U.S. Food and Drug Admin...ion (LAI) for acute and maintenance treatment of s...rk with the agency on the new drug,application (N...nal clinical trials for the continued,review of t...
    (Date:1/7/2009)...iantan Puhua Hospital Stem Cells Center ( http://w...sing stem cells to effectively treat neurological ...enced additions to its medical and research staff ... capabilities for growing numbers of incoming inte... the distinguished Dr. Jiang Ping, who was named C...
    (Date:1/6/2009)...wswire/ -- The Michael J. Fox Foundation awarded a...arch teams for pre-clinical research on potential ... funding was awarded under the Foundation,s Thera...st launched in 2006, supports and bolsters industr...s part of MJFF,s focus on ,de-risking, preclinic...
    (Date:1/5/2009)... Cylene Pharmaceuticals announced today that it ha...K2 protein kinase inhibitor, CX-4945, in patients ...r multiple myeloma. The primary endpoints of the o...ety, tolerance and PK properties of CX-4945 and to...In addition, multiple mechanism-related pharmacody...
    Breaking Medicine Technology:FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 2FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 3FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 4FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 5FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 6Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 3The SCOOTER Store Donates Power Wheelchair to New Braunfels Car Crash Victim 11215 1The SCOOTER Store Donates Power Wheelchair to New Braunfels Car Crash Victim 11215 2Emageon Inc to Host Fourth Quarter 2007 Financial Results Conference Call February 21 2008 11212 1Emageon Inc to Host Fourth Quarter 2007 Financial Results Conference Call February 21 2008 11212 2Inverness Medical Innovations to Present at 2008 UBS Global Healthcare Services Conference on February 13 2008 11209 1Inverness Medical Innovations to Present at 2008 UBS Global Healthcare Services Conference on February 13 2008 11209 2ThermoGenesis Corp Reports 48 Percent Growth in Second Quarter Revenues Year Over Year 3090 1ThermoGenesis Corp Reports 48 Percent Growth in Second Quarter Revenues Year Over Year 3090 2ThermoGenesis Corp Reports 48 Percent Growth in Second Quarter Revenues Year Over Year 3090 3ThermoGenesis Corp Reports 48 Percent Growth in Second Quarter Revenues Year Over Year 3090 4ThermoGenesis Corp Reports 48 Percent Growth in Second Quarter Revenues Year Over Year 3090 5ThermoGenesis Corp Reports 48 Percent Growth in Second Quarter Revenues Year Over Year 3090 6ThermoGenesis Corp Reports 48 Percent Growth in Second Quarter Revenues Year Over Year 3090 7ThermoGenesis Corp Reports 48 Percent Growth in Second Quarter Revenues Year Over Year 3090 8
    ...150%; mso-hyphenate: none">,BUDAPEST, Hungary, Jun...ousands of patients with cancer from suffering,unn...Congress of,the European Association for Palliativ...igated whether this first in class novel,formulati...rt,duration of effect, mirroring the breakthrough ...
    ...were Migraine Free,Compared to Placebo, CHICAGO, J...ge,trials show that Trexima, when taken early, was...ng all traditional migraine,symptoms at two and fo...let. The findings will be presented tomorrow at th...eadache Society. , In addition to head pain, migra...
    Other Medicine Technology:Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 2Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 3Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 4Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 5Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 6Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free,Response Across Multiple Attacks 2Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free,Response Across Multiple Attacks 3Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free,Response Across Multiple Attacks 4